The immediate initiation group started treatment when their CD4 + count exceeded 500 cells/ μ L, while the delayed start group deferred treatment initiation until their CD4 + count had fallen to 350 cells/ μ L or at any point where the study participant developed AIDS. Here, CD4 is linked to AIDS.